FluMist approved for self-administration in the US
Sep 20, 2024 · Only influenza vaccine approved for self- or caregiver-administration at home, expanding options for influenza protection. WILMINGTON, Del., September 20, 2024 – FLUMIST ® has been approved in the US as the only self-administered influenza vaccine.
FluMist approved for self-administration in the US - astrazeneca.com
Sep 20, 2024 · FluMist has been approved in the US as the only self-administered influenza vaccine. FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age. 1
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver ...
Sep 20, 2024 · FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age. FluMist is sprayed into the nose and has been...
FDA approves first flu vaccine that can be self-administered at …
Sep 20, 2024 · AstraZeneca plans to make the vaccine available for self-administration through a third-party online pharmacy, which will prescribe and ship the vaccine after reviewing a screening and...
US FDA approves AstraZeneca's self-administered nasal spray flu …
Sept 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's (AZN.L) nasal spray flu vaccine for self-administration, making it the first of its kind....
Nasal Flu Vaccine FluMist Gets FDA Approval for At-Home Use
Oct 4, 2024 · Recently, the Food and Drug Administration (FDA) removed those obstacles by approving the at-home use of FluMist®, an influenza vaccine administered by nasal spray. Made by AstraZeneca, FluMist will be available for home use starting in the fall of 2025.
FDA approves first self-administered flu vaccine spray - CBS News
Sep 20, 2024 · The FDA says patients will still need to get a prescription for the vaccine from a health care provider. AstraZeneca says it plans to sell FluMist directly to patients through an online...
Next season, you may be able to take your flu vaccine at home
Oct 24, 2023 · The US Food and Drug Administration is reviewing an application for the nasal spray flu vaccine FluMist to be able to be self-administered at home, drugmaker AstraZeneca said Tuesday. The...
US Food and Drug Administration accepts for review AstraZeneca…
Oct 24, 2023 · AstraZeneca’s Supplemental Biologics License Application (sBLA) for the approval of a self- or caregiver-administered option for FluMist Quadrivalent, a needle-free nasal spray, has been accepted for review by the US Food and Drug Administration (FDA).
Nasal Flu Vaccine Is Approved for At-Home Use
Sep 20, 2024 · The Food and Drug Administration on Friday authorized at-home use of FluMist, opening the door for needle-shy people to have easy access to a nasal spray vaccine that is potentially lifesaving.